Company Filing History:
2 out of 11 
2 out of 55 Years Active: 2019-2020
Title: Kiichi Kubota: Innovator in Hemagglutinin-Binding Peptides
Introduction
Kiichi Kubota is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that combat influenza viruses. With a total of two patents to his name, Kubota's work is recognized for its potential impact on public health.
Latest Patents
Kubota's latest patents focus on hemagglutinin-binding peptides. These peptides are designed to produce an anti-influenza virus effect that surpasses that of existing peptides. The patents disclose hemagglutinin-binding peptides comprising polypeptides with specific amino acid sequences, which are crucial for their effectiveness against influenza viruses.
Career Highlights
Throughout his career, Kiichi Kubota has worked with prominent organizations such as Peptidream Inc. and the Tokyo Metropolitan Institute of Medical Science. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in the medical field.
Collaborations
Some of his notable coworkers include Patrick Reid and Michinori Kohara. Their collaboration has likely enriched the research environment and fostered innovative ideas in the development of peptides.
Conclusion
Kiichi Kubota's work in the field of hemagglutinin-binding peptides showcases his dedication to advancing medical science. His innovative patents hold promise for improving treatments for influenza, highlighting the importance of research and collaboration in the fight against viral infections.